A Multicenter Non-randomized Phase II Study to Evaluate Nab-paclitaxel in Metastatic Breast Cancer Patients Failing a Solvent Based Taxane as (Neo-)Adjuvant Treatment (Tiffany).
Phase of Trial: Phase II
Latest Information Update: 30 Nov 2013
At a glance
- Drugs Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms Tiffany
- 03 Nov 2012 Status changed from recruiting to discontinued as reported by European Clinical Trials Database record.
- 17 Aug 2011 New trial record